Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
No news for this category today.
----------------------------------------------
** CANCER / ONCOLOGY News **
Cancer Treatment Application Of The Aethlon Hemopurifier® Published In Journal Of Translational Medicine
http://www.medicalnewstoday.com/articles/116229.php
Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that a peer reviewed scientific paper coauthored by Aethlon researchers has been published in the Journal of Translational Medicine. The paper entitled, "Exosomes as a Tumor Immune Escape Mechanism: Possible Therapeutic Implications" discusses the mechanism by which exosomes released by cancerous tumors are able to kill off immune cells in cancer patients.
Cornerstone Pharmaceuticals Announces Approval To Conduct Phase I/II Clinical Trial Of CPI-613 In Cancer Patients By US FDA
http://www.medicalnewstoday.com/articles/116207.php
Cornerstone Pharmaceuticals, Inc., a privately held pharmaceutical company, announced today that it has received clearance from the US Food and Drug Administration (FDA) to begin a Phase I/II clinical trial evaluating the safety and early efficacy of its first-in-class Altered Energy Metabolism-Directed (AEMD) compound, CPI-613, in a variety of cancer types.
Ceplene® Receives Positive European Opinion For Approval From CHMP - Acute Myeloid Leukemia
http://www.medicalnewstoday.com/articles/116199.php
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion regarding the marketing authorization for Ceplene® (histamine dihydrochloride), for the remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia (AML) in first remission.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
Launch Of New Interactive Non-Small Cell Lung Cancer Resource For Physicians
http://www.medicalnewstoday.com/articles/116241.php
EPG Health Media, developers of e-communication and clinical information solutions for the health sector, today announced the launch of a new interactive Non-small Cell Lung Cancer Knowledge Centre within the web-based physician resource <a href="http://www.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Ceplene® Receives Positive European Opinion For Approval From CHMP - Acute Myeloid Leukemia
http://www.medicalnewstoday.com/articles/116199.php
EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion regarding the marketing authorization for Ceplene® (histamine dihydrochloride), for the remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia (AML) in first remission.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
No news for this category today.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment